Pulmonary perfusion defect

A pulmonary perfusion defect occurs when blood flow to specific regions of the lungs is reduced or absent, impairing oxygen delivery and gas exchange. Such defects are commonly associated with pulmonary embolism, chronic thromboembolic pulmonary hypertension, or localized vascular obstruction due to structural abnormalities or vasculitis. Depending on the size and location of the affected area, patients may experience shortness of breath, chest discomfort, or fatigue, while small or subclinical defects can remain asymptomatic until progression occurs. Evaluation of a pulmonary perfusion defect combines imaging and functional assessment. Lung perfusion scans, often paired with ventilation studies in a V/Q scan, allow visualization of perfusion abnormalities and help differentiate vascular from airway causes of respiratory impairment. Computed tomography pulmonary angiography provides high-resolution anatomical detail, enabling identification of thrombi or vascular narrowing. Invasive hemodynamic monitoring can quantify pressure gradients and guide therapy in complex cases.

Management strategies target restoring or compensating for compromised perfusion. Acute thromboembolic events are treated with anticoagulation, thrombolysis, or catheter-directed interventions, while chronic perfusion defects may require surgical procedures such as pulmonary thromboendarterectomy. Supportive care, including oxygen therapy and rehabilitation, aids in symptom relief and functional improvement. Emerging research focuses on molecular therapies and regenerative approaches to enhance microvascular integrity and optimize perfusion. By combining precise imaging, tailored interventions, and supportive measures, pulmonary perfusion defect management seeks to improve gas exchange, reduce cardiovascular strain, and enhance overall respiratory function in affected individuals.